BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27610753)

  • 1. Fluorine-18 patents (2009-2015). Part 2: new radiochemistry.
    Mossine AV; Thompson S; Brooks AF; Sowa AR; Miller JM; Scott PJ
    Pharm Pat Anal; 2016 Sep; 5(5):319-49. PubMed ID: 27610753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Exposition of
    Saxena P; Mahmood T; Dixit M; Gambhir S; Ahsan F
    Curr Radiopharm; 2021; 14(2):92-100. PubMed ID: 33261547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18 patents (2009-2015). Part 1: novel radiotracers.
    Brooks AF; Drake LR; Stewart MN; Cary BP; Jackson IM; Mallette D; Mossine AV; Scott PJ
    Pharm Pat Anal; 2016; 5(1):17-47. PubMed ID: 26670619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium-68: methodology and novel radiotracers for positron emission tomography (2012-2017).
    Tanzey SS; Thompson S; Scott PJ; Brooks AF
    Pharm Pat Anal; 2018 Sep; 7(5):193-227. PubMed ID: 30066605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review.
    Nerella SG; Bhattacharya A; Thacker PS; Tulja S
    Expert Opin Ther Pat; 2022 Apr; 32(4):455-473. PubMed ID: 35072592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-Driven Radiochemistry with Fluorine-18, Carbon-11 and Zirconium-89.
    Lin D; Lechermann LM; Huestis MP; Marik J; Sap JBI
    Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202317136. PubMed ID: 38135665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in [
    Francis F; Wuest F
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosyntheses using fluorine-18: the art and science of late stage fluorination.
    Cole EL; Stewart MN; Littich R; Hoareau R; Scott PJ
    Curr Top Med Chem; 2014; 14(7):875-900. PubMed ID: 24484425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocatalysis in radiochemistry: Enzymatic incorporation of PET radionuclides into molecules of biomedical interest.
    da Silva ES; Gómez-Vallejo V; López-Gallego F; Llop J
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):332-354. PubMed ID: 29231247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of PET Radiochemistry, Part 1: The Covalent Labels
    Pichler V; Berroterán-Infante N; Philippe C; Vraka C; Klebermass EM; Balber T; Pfaff S; Nics L; Mitterhauser M; Wadsak W
    J Nucl Med; 2018 Sep; 59(9):1350-1354. PubMed ID: 30042159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 labeling of small molecules: the use of 18F-labeled aryl fluorides derived from no-carrier-added [18F]fluoride as labeling precursors.
    Wuest F
    Ernst Schering Res Found Workshop; 2007; (62):51-78. PubMed ID: 17172152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18 radiochemistry, labeling strategies and synthetic routes.
    Jacobson O; Kiesewetter DO; Chen X
    Bioconjug Chem; 2015 Jan; 26(1):1-18. PubMed ID: 25473848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography radiotracers for imaging hypoxia.
    Wuest M; Wuest F
    J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-11 patents (2012-2022): synthetic methodologies and novel radiotracers for PET imaging.
    Nerella SG; Singh P; Tulja S
    Expert Opin Ther Pat; 2022 Jul; 32(7):817-831. PubMed ID: 35451896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of [
    Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
    Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
    Gomes PMO; Silva AMS; Silva VLM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18: A radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis.
    Goud NS; Joshi RK; Bharath RD; Kumar P
    Eur J Med Chem; 2020 Feb; 187():111979. PubMed ID: 31877537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.